Your account is not claimed yet. You can sign up with ORCID to claim your account.

Jill Bargonetti

Years Active: 2019-2022
Publications (10 Years): 5

City University of New York Graduate School and University Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

City University of New York Graduate School and University Center Sep 1o 1994

United States

Professor :: Biology

Publications

Devon Lundine, George K Annor, Valery Chavez, Styliana Maimos, Zafar Syed, Shuhong Jiang, Viola Ellison, Jill Bargonetti
The C-terminus of Gain-of-Function Mutant p53 R273H Is Required for Association with PARP1 and Poly-ADP-Ribose. Molecular cancer research : MCR 20 (12) (2022)
Thomas Wilson, Giacomo Pirovano, Gu Xiao, Zachary Samuels, Sheryl Roberts, Tara Viray, Navjot Guru, Pat Zanzonico, Marc Gollub, Naga Vara Kishore Pillarsetty, Thomas Reiner, Jill Bargonetti
PARP-Targeted Auger Therapy in p53 Mutant Colon Cancer Xenograft Mouse Models. Molecular pharmaceutics 18 (9) (2021)
Jun Yeob Kim, Rusia Lee, Gu Xiao, Dominique Forbes, Jill Bargonetti
MDM2-C Functions as an E3 Ubiquitin Ligase. Cancer management and research 12 (2020)
Gu Xiao, George K Annor, Kimberly Fung, Outi Keinänen, Brian M Zeglis, Jill Bargonetti
Targeting Triple Negative Breast Cancer with a Nucleus-Directed p53 Tetramerization Domain Peptide. Molecular pharmaceutics 18 (1) (2020)
Chong Gao, Gu Xiao, Alessandra Piersigilli, Jiangtao Gou, Olorunseun Ogunwobi, Jill Bargonetti
Context-dependent roles of MDMX (MDM4) and MDM2 in breast cancer proliferation and circulating tumor cells. Breast cancer research : BCR 21 (1) (2019)

Jill Bargonetti.css-eqlu8i{font-size:small;padding-left:4px;}